Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade F 0.75 5.13% 0.04
AYTU closed up 5.13 percent on Friday, February 21, 2020, on 6.41 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical AYTU trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Resistance Bearish 5.13%
Volume Surge Other 5.13%
Calm After Storm Range Contraction 5.13%
Down 3 Days in a Row Weakness 5.13%
Lower Bollinger Band Touch Weakness 5.13%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Healthcare Organ Systems Prostate Cancer Alcohols Hormones Ketones Company's Pipeline Urinary Tract Infections Androstanes Male Infertility Testosterone

Is AYTU a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.61
52 Week Low 0.65
Average Volume 206,224
200-Day Moving Average 1.27
50-Day Moving Average 0.82
20-Day Moving Average 0.75
10-Day Moving Average 0.75
Average True Range 0.08
ADX 13.66
+DI 22.99
-DI 18.27
Chandelier Exit (Long, 3 ATRs ) 0.71
Chandelier Exit (Short, 3 ATRs ) 0.90
Upper Bollinger Band 0.82
Lower Bollinger Band 0.68
Percent B (%b) 0.5
BandWidth 18.84
MACD Line -0.02
MACD Signal Line -0.03
MACD Histogram 0.0047
Fundamentals Value
Market Cap 3.02 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.89
Resistance 3 (R3) 0.88 0.82 0.86
Resistance 2 (R2) 0.82 0.79 0.83 0.85
Resistance 1 (R1) 0.79 0.77 0.81 0.80 0.85
Pivot Point 0.73 0.73 0.74 0.74 0.73
Support 1 (S1) 0.70 0.70 0.72 0.71 0.65
Support 2 (S2) 0.64 0.68 0.65 0.65
Support 3 (S3) 0.61 0.64 0.64
Support 4 (S4) 0.62